Sonoma Pharmaceuticals, Inc.
corporate_fare Company Profile
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SNOA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Sonoma Pharmaceuticals Appoints Biotech Finance Veteran Vanessa Jacoby to Board, Audit Chair
- Sonoma Pharmaceuticals Files Investor Presentation Highlighting Strong Growth, New Products, and Expanded Distribution
Financial Snapshot
Fiscal year ended March 31, 2026
Revenue
$19.53M
Net Income
-$3.17M
Diluted EPS
-$1.89
Op. Cash Flow
-$3.93M
Free Cash Flow
-$4.13M
Gross Profit
$7.42M
Operating Income
-$2.46M
Cash & Equivalents
$2.4M
Total Debt
$222K
Debt / Equity
0.07×
Net Margin
-16.3%
Shares Outstanding
1.8M sh
Source: 10-K · filed 2026-06-16 · accession 0001683168-26-004871
show_chartPrice Chart
Loading chart...